Zimbabwe has turned down a significant American health deal worth $367m (£272m) spanning five years over Washington's request for confidential biological samples.
This move was revealed following a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the arrangement was "skewed".
An official representative later stated that the US was seeking health data for scientific study and commercial gain while was not willing to guarantee the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for more talks to reach a agreement acceptable to all parties so the nation's vital HIV treatment initiative can be sustained.
Broader Background
This development follows a similar situation in Kenya, where a high court suspended a related deal with the US after concerns were raised about the safety of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had overseen aid for the American government, but Trump claimed its spending was "inefficient" and his administration was pursuing direct bilateral agreements to enhance transparency and responsibility.
According to statements, Sixteen nations in Africa have so far agreed to similar health pacts, constituting over $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded initiatives," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, with no corresponding guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," his statement read.
"In essence, our country would supply the basic resources for medical research without any assurance that the resulting innovations would be accessible to our people if a future health crisis emerge."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting frameworks previously established via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with future pandemics.
"This mechanism is designed to guarantee that when a nation provides its data, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage continued discussions with our American counterparts on how future collaboration could be designed in a way that honours the independence and dignity of both nations."
Medical Community Response
Medical experts said it understood the government's concerns, but suggested that negotiations must proceed considering a large portion of the country's Aids initiatives depended on external financing.
"In cases where specific concerns exist, including those involving information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group commented.
This impasse underscores the ongoing challenges between accepting crucial foreign assistance and protecting a country's data in an increasingly data-driven world.